References
- World Health Organization. A study on the public health and socioeconomic impact of substandard and falsified medical products. Geneva; 2017. WHO/EMP/RHT/2017.02. Available: https://www.who.int/medicines/regulation/ssffc/publications/se-study-sf/en/. Accessed 20 Apr 2020.
- Newton PN, Caillet C, Guerin PJ. A link between poor quality antimalarials and malaria drug resistance? Expert Rev Anti-Infect Ther. 2016;14(6):531–533.
- Ozawa S, Evans DR, Bessias S, Haynie DG, Yemeke TT, Laing SK, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries. JAMA Netw Open. 2018;1(4):e181662.
- World Health Organization. (22–31 May 2017). Seventieth World Health Assembly. Annex A70/23. Appendix 3. Geneva, Switzerland. Available: https://www.who.int/medicines/regulation/ssffc/A70_23-en1.pdf?ua=1. Accessed 2 Sept 2019.
- World Health Organization. Norms and standards. 70 years of WHO standards on medicines quality. Expert committee on specifications for pharmaceutical preparations, 1947-2017: addressing changing public health challenges. Who Drug Info 2017. 2017;31(1):15–26. Available: https://www.who.int/medicines/publications/druginformation/issues/WHO_DI_31-1_Norms-Standards.pdf?ua=1. Accessed 20 Apr 2020.
- World Health Organization. WHO Global Surveillance and Monitoring System for substandard and falsified medical products. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Available: https://www.who.int/medicines/regulation/ssffc/publications/gsms-report-sf/en/ Accessed 20 Apr 2020.
- World Health Organization>. A Model quality assurance system for procurement agencies. In: Annex III of the WHO technical report series 986: WHO Expert Committee on Specifications for Pharmaceutical Preparations, forty-eighth report. Geneva. Available: https://www.who.int/medicines/areas/quality_safety/quality_assurance/expert_committee/ISBN9789241209861-TRS986.pdf. Accessed 20 Apr 2020.
- Hamilton WL, Doyle C, Halliwell-Ewen M, Lambert G. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Health Policy Plan. 2016;31(10):1448–1466.
- S, Fernandez FM, Newton PN, Caillet C. Field detection devices for screening the quality of medicines: a systematic review. BMJ Glob Health. 2018;3:e000725.
- Kovacs S, Hawes SE, Maley SN, Mosites E, Wong L. Technologies for detecting falsified and substandard drugs in low and middle-income countries. Plos One. 2014;9(3):e90601.
- World Health Professions Alliance. Be Aware: Tool for visual inspection of medicines; 2011. p. 4. Available: https://www.whpa.org/sites/default/files/2018-12/Toolkit_BeAware_Inspection.pdf. Accessed 20 Apr 2020.
- International Pharmaceutical Federation, United States Pharmacopeia. A checklist for visual inspection of medicines. Available: https://www.fip.org/files/fip/counterfeit/VisualInspection/A%20tool%20for%20visual%20inspection%20of%20medicines%20EN.pdf. Accessed 20 Apr 2020.
- Schiavetti B, Wynendaele E, De Spiegeleer B, Mbinze GJ, Kalenda N, Marini R, et al. The quality of medicines used in children and supplied by private pharmaceutical wholesalers in kinshasa, democratic Republic of Congo: a prospective survey. Am J Trop Med Hyg. 2018;98(3):894–903. Available:https://doi.org/10.4269/ajtmh.17-0732. Accessed 20 Apr 2020.
- World Health Organization. The International Pharmacopoeia. 6th ed; 2016. Available: https://apps.who.int/phint/2016/index.html#p/home. Accessed 20 Apr 2020.
- World Health Organization. Quality Assurance of pharmaceuticals, WHO guidelines, good practices, related regulatory guidance and GXP training materials. 2016. Available: http://digicollection.org/whoqapharm/p/about/. Accessed 20 Apr 2020.
- World Health Organization. Guidelines on packaging for pharmaceutical products. WHO Tech Rep Ser. 2002;902(902):120–54. Available from: https://apps.who.int/iris/bitstream/handle/10665/42424/WHO_TRS_902.pdf. Accessed 20 Apr 2020.
- World Health Organization. Model List of Essential Medicines, 21st List, 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC.-SA 3.0 IGO.
- World Health Organization. Model List of Essential Medicines for Children, 7th List, 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC.-SA 3.0 IGO.
- Ravinetto R, Pinxten W, Rago L. Quality of medicines in resource-limited settings: need for ethical guidance. Global Bioethics. 2018;29(1):81–94.
- Lehmann A, et al. Drug Quality In South Africa: A Field Test. J Pharm Sci. 2018. https://doi.org/10.1016/j.xphs.2018.06.012 [Epub ahead of print].